ValueScreener

ValueScreener company report

The Ensign Group, Inc. (ENSG)

NASDAQ / Healthcare / Medical - Care Facilities

Share price

178.11 USD Market dataClose of Oct 15, 2026

Market capitalisation

10.38B USD Market dataClose of Oct 15, 2026
Market data
Oct 15, 2026
Filed accounts
FY2025, filed Feb 4, 2026
Ratios computed
Oct 15, 2026
Filed years
16, FY2009 to FY2025
Four kinds of sourceSEC filingCompany statementMarket dataComputedWhat each means
SEC filingFiled with the SEC
Read from a statement the company filed with the SEC, with the form, fiscal year, filing date and accession beside it.
Company statementCompany statement
What the company says about itself in a filing: an 8-K item, the auditor, its own segment names.
Market dataMarket data
Prices, market value and what analysts publish, with the date they are as of.
ComputedComputed by ValueScreener
Worked out by us from the other three, with the inputs and the formula one press away. A score is a research output, not a rating or a recommendation.
Reading

1 of 10

Overview

What the business is, what it costs, and how it reads on four questions.

Market dataSEC filingComputed

Four questions, at a glance

Quality

Return on invested capital, after tax

8.2% Computed

From the FY2025 filing

Read quality

Valuation

Price to earnings

29.69x Computed

FY2025 accounts, priced at the latest close

Read valuation

Cash generation

Dividend yield

0.1% Computed

FY2025 accounts, priced at the latest close

Read cash generation

Revenue and net income, as filed

FY2016 Revenue: 1.65B USDFY2016 Net income: 50.0M USDFY2017 Revenue: 1.85B USDFY2017 Net income: 40.5M USDFY2018 Revenue: 1.75B USDFY2018 Net income: 92.4M USDFY2019 Revenue: 2.04B USDFY2019 Net income: 110.5M USDFY2020 Revenue: 2.40B USDFY2020 Net income: 170.5M USDFY2021 Revenue: 2.63B USDFY2021 Net income: 194.7M USDFY2022 Revenue: 3.03B USDFY2022 Net income: 224.7M USDFY2023 Revenue: 3.73B USDFY2023 Net income: 209.4M USDFY2024 Revenue: 4.26B USDFY2024 Net income: 298.0M USDFY2025 Revenue: 5.06B USDFY2025 Net income: 344.0M USD
Revenue Net income10 filed fiscal years, from the annual reports; the table in Filings names each document.
Named tests met
1 of 30 Which tests
The business, and the score behind its five axes

The reading, in brief

Is it cheap

Price to earnings is 29.69x at the close of 2026-10-15 on FY2025 figures; the lines are 15.00x (Graham's defensive ceiling) and, by market convention, 10.00x, 25.00x and 40.00x, and this sits between 25.00x and 40.00x.

Today, against the Healthcare sector (223 companies), 29.69x sits at the 57th percentile; the middle half of that group runs from 13.52x to 42.98x.

Is it good

Return on invested capital was 8.2% in FY2025, in the band labelled "Around the cost of capital" (8.0% to 12.0%), on lines anchored on Damodaran's cost-of-capital data.

Today, against the Healthcare sector (233 companies), 8.2% sits at the 60th percentile; the middle half of that group runs from -37.4% to 12.8%.

Is it safe

Interest coverage was 53.24x in FY2025, in the band labelled "Comfortable" (6.00x and above), on lines anchored on Damodaran's interest-coverage table, suggesting an interest bill operating profit covers many times over.

Year by year against peers
Whether The Ensign Group, Inc.'s return on invested capital stayed above the median of the Healthcare sector, year by year. (FY2018 to FY2025, 8 fiscal years of The Ensign Group, Inc. with a comparable figure)
The direction
Which way The Ensign Group, Inc.'s return on equity has moved, and how steadily. (FY2016 to FY2025, 10 filed years of The Ensign Group, Inc.)
What could explain it
What in The Ensign Group, Inc.'s filed statements could explain the movements. (5 readings drawn from the statement lines The Ensign Group, Inc. filed)
What to check next
What to check next on The Ensign Group, Inc., and where in its filings. (2 questions for The Ensign Group, Inc.)
In one paragraph
One paragraph on The Ensign Group, Inc.'s returns, cash, balance sheet and price. (12 of sixteen figures read for The Ensign Group, Inc.)

These are ENSG’s filed figures. The research desk says what they mean, against peers and its own years, with what to check next.

Research ENSGPart of Serious. New accounts start with 30 days of Professional, free, no card.

2 of 10

What changed

The newest filing, what it moved, and when the next one is due.

SEC filingCompany statement

The newest accounts on file are the FY2025 annual report: 10-K, filed Feb 4, 2026, accession 0001125376-26-000007.

3 of 10

Quality

The returns the business earns on its capital, and the margins behind them.

SEC filingComputed

The Ensign Group, Inc: returns on capital and margins, each with its source
FigureValue, source and document
Return on invested capital, after tax8.2% ComputedFY2025 10-K, filed Feb 4, 2026, 0001125376-26-000007
Return on equity15.4% ComputedFY2025 10-K, filed Feb 4, 2026, 0001125376-26-000007
Return on capital employed, pre-tax9.3% ComputedFY2025 10-K, filed Feb 4, 2026, 0001125376-26-000007
Return on assets6.3% ComputedFY2025 10-K, filed Feb 4, 2026, 0001125376-26-000007
Gross margin20.5% ComputedFY2025 10-K, filed Feb 4, 2026, 0001125376-26-000007
Operating margin8.4% ComputedFY2025 10-K, filed Feb 4, 2026, 0001125376-26-000007
Net margin6.8% ComputedFY2025 10-K, filed Feb 4, 2026, 0001125376-26-000007
ENSG 6.8%
DVA 5.5%FMS 5.0%UHS 8.6%EHC 9.5%THC 11.1%
5.0%11.1%
Net margin: ENSG against the 5 companies named under Valuation context, each as filed for its own latest year. Placement only: no average is drawn.

4 of 10

Financial strength

What it owes against what it owns, and whether it can meet what falls due.

SEC filingComputedCompany statement

The Ensign Group, Inc: leverage, liquidity and distress, each with its source
FigureValue, source and document
Debt to equity0.99 ComputedFY2025 10-K, filed Feb 4, 2026, 0001125376-26-000007
Current ratio1.42 ComputedFY2025 10-K, filed Feb 4, 2026, 0001125376-26-000007
Quick ratio1.42 ComputedFY2025 10-K, filed Feb 4, 2026, 0001125376-26-000007
Interest coverage53.24x ComputedFY2025 10-K, filed Feb 4, 2026, 0001125376-26-000007
Altman Z-score3.66 ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 4, 2026, 0001125376-26-000007
Net debt1.63B ComputedFY2025 10-K, filed Feb 4, 2026, 0001125376-26-000007
Total assets 5.46BTotal liabilities 3.23BShareholders' equity 2.23BOwnsOwes, and equity
Total assets Total liabilities Shareholders’ equity
The balance sheet, line by line

Financial health

What The Ensign Group, Inc owned and owed at the end of fiscal 2025, from the balance sheet it filed (10-K, filed Feb 4, 2026, 0001125376-26-000007).

The Ensign Group, Inc: balance sheet position
Total assets5.46B FiledFY2025 10-K, filed Feb 4, 2026
Total liabilities3.23B FiledFY2025 10-K, filed Feb 4, 2026
Shareholders' equity2.23B FiledFY2025 10-K, filed Feb 4, 2026
Cash572.4M FiledFY2025 10-K, filed Feb 4, 2026
Total debt2.21B FiledFY2025 10-K, filed Feb 4, 2026
Net debt1.63B
Current ratio1.42
Debt to equity0.99

Read from the filed balance sheet for each year, with the income statement of the same year supplying operating profit where a ratio needs it. Nothing here is a view on whether this company is sound.

5 of 10

Valuation context

What the market charges for it, against its own record and companies like it.

Market dataSEC filingComputed

The Ensign Group, Inc: what the market charges, each with its source
FigureValue, source and document
Price to earnings29.69x ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 4, 2026, 0001125376-26-000007
P/E on trailing twelve months27.56x ComputedClose of Oct 15, 2026 · Trailing four quarters, each as known on the day; the quarterly filings are listed under Filings
Price to book4.70x ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 4, 2026, 0001125376-26-000007
Price to sales2.07x ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 4, 2026, 0001125376-26-000007
Enterprise value to EBIT28.66x ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 4, 2026, 0001125376-26-000007
Enterprise value to EBITDA23.01x ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 4, 2026, 0001125376-26-000007
Price to earnings over growth2.20 ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 4, 2026, 0001125376-26-000007
Diluted earnings per share5.84 USD FiledFY2025 10-K, filed Feb 4, 2026, 0001125376-26-000007
Graham number71.54 USD ComputedFY2025 10-K, filed Feb 4, 2026, 0001125376-26-000007

We publish no fair value or price target of our own. Value ENSG on your own assumptions in the DCF workbench, starting from the filed figures.

Its own record, and companies like it

Valuation

What the market charges for The Ensign Group, Inc today, and the multiples it has carried. No value of ours: the figures are the filings’ and the market’s.

The Ensign Group, Inc: valuation
Share price178.11 USD
Market capitalisation10.38B USD
Enterprise value to EBITDA23.01x
Graham number71.54 USD
Diluted earnings per share, FY20255.84 USD

Price to earnings on trailing twelve months, a different basis from the fiscal-year P/E above, since Oct 3, 2016: low 12.69x, median 25.85x, high 39.50x, latest 27.56x. 2,522 trading days with a meaningful ratio. Each close over the trailing twelve months of earnings as known that day: a quarter counts from the day it was filed.

Companies like The Ensign Group, Inc

  1. DaVita Inc. (DVA)Market cap 12.07B USD
  2. Fresenius Medical Care AG & Co. KGaA (FMS)Market cap 11.78B USD
  3. Universal Health Services, Inc. (UHS)Market cap 11.04B USD
  4. Encompass Health Corporation (EHC)Market cap 12.60B USD
  5. Tenet Healthcare Corporation (THC)Market cap 22.15B USD

Same industry (Medical - Care Facilities) and size band (Large, 10B to 200B), nearest in market value, net margin and current ratio. Each of those counts equally, by how many of the companies considered sit between the two on it. Closest first: the order is likeness and nothing else.

6 of 10

Cash generation

Whether profit arrives as cash, and what is paid back to shareholders.

SEC filingComputed

The Ensign Group, Inc: cash generation and what is paid out, each with its source
FigureValue, source and document
Free cash flow yield
Why n/a

We do not hold this figure for this company, so there is nothing to show.

n/a ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 4, 2026, 0001125376-26-000007
Free cash flow
Why n/a

The FY2025 filing carries no free cash flow we could read.

n/a ComputedFY2025 10-K, filed Feb 4, 2026, 0001125376-26-000007
Free cash flow margin
Why n/a

No free cash flow, and no operating cash flow and capital expenditure pair, is filed for this year.

n/a ComputedFY2025 10-K, filed Feb 4, 2026, 0001125376-26-000007
Dividend yield0.1% ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 4, 2026, 0001125376-26-000007
Payout ratio4.2% ComputedFY2025 10-K, filed Feb 4, 2026, 0001125376-26-000007
FY2016 Free cash flow: 8.2M USDFY2016 Net income: 50.0M USDFY2017 Free cash flow: 25.5M USDFY2017 Net income: 40.5M USDFY2018 Free cash flow: 159.4M USDFY2018 Net income: 92.4M USDFY2019 Free cash flow: 120.7M USDFY2019 Net income: 110.5M USDFY2020 Net income: 170.5M USDFY2021 Net income: 194.7M USDFY2022 Net income: 224.7M USDFY2023 Net income: 209.4M USDFY2024 Net income: 298.0M USDFY2025 Net income: 344.0M USD
Free cash flow Net incomeProfit that arrives as cash stands level with net income; a gap year after year is worth reading about.

7 of 10

Filings

Every figure, the year it is for and the document it was read from.

SEC filingMarket data

The filed figures

Computed from the accounts this company filed with the SEC and, in a ratio with a price in it, the last close, dated on this page. Every filed figure below carries the fiscal year and the filing date its accounts were read from, and every blank carries the reason it is blank. Nothing here is a view on this company.

The Ensign Group, Inc.: the eight ratios, with the fiscal year and filing date behind each.
FigureValueYearAs of
29.69xFY2025Oct 15, 2026
4.70xFY2025Oct 15, 2026
28.66xFY2025Oct 15, 2026
n/aFY2025Oct 15, 2026
n/a The filed cash flow statement reports neither free cash flow nor the operating cash flow and capital spending it is built from.
8.2%FY2025Feb 4, 2026
0.1%FY2025Oct 15, 2026
0.99FY2025Feb 4, 2026
1.42FY2025Feb 4, 2026
2.07xFY2025Oct 15, 2026
2.20FY2025Oct 15, 2026
3.66FY2025Oct 15, 2026
-2.53FY2025Feb 4, 2026
5/9FY2025Feb 4, 2026

The figures are computed from the accounts for fiscal 2025, the newest full year on file. 16 filed fiscal years on record, FY2009 to FY2025, from SEC EDGAR. Prices as of Oct 15, 2026. Ratios recomputed Oct 15, 2026. Two facts, because a recompute is not a fresh quote.

The year and the filing date name the statement each figure’s accounts are read from, and they stand even where the figure itself could not be computed: the line beneath a blank says what that statement did not carry. A figure’s name opens its formula and the filings behind it; a statement that names no SEC filing has no filing date, and reads n/a.

Ten years of filed figures, year by year

Ten years of filed figures

10 filed fiscal years, FY2016 to FY2025, read from the annual reports The Ensign Group, Inc filed with the SEC. Each year names its filing. Amounts in USD, as filed.

The Ensign Group, Inc: revenue, earnings, free cash flow and returns, by fiscal year, with the filing each year was read from
YearRevenueOperating incomeNet incomeEPS, dilutedFree cash flowOperating marginReturn on equityFiling
FY20255.06B425.3M344.0M5.84n/a8.4%15.4%10-K, Feb 4, 20260001125376-26-000007
FY20244.26B358.3M298.0M5.12n/a8.4%16.2%10-K, Feb 5, 20250001125376-25-000021
FY20233.73B255.4M209.4M3.65n/a6.8%14.0%10-K, Feb 1, 20240001125376-24-000018
FY20223.03B296.8M224.7M3.95n/a9.8%18.0%10-K, Feb 2, 20230001125376-23-000018
FY20212.63B260.5M194.7M3.42n/a9.9%19.1%10-K, Feb 9, 20220001125376-22-000019
FY20202.40B223.2M170.5M3.06n/a9.3%20.8%10-K, Feb 3, 20210001125376-21-000020
FY20192.04B129.2M110.5M1.97120.7M6.3%16.9%10-K, Feb 5, 20200001125376-20-000018
FY20181.75B84.9M92.4M1.70159.4M4.8%15.6%10-K, Feb 6, 20190001125376-19-000016
FY20171.85B43.2M40.5M0.7725.5M2.3%8.2%10-K, Feb 8, 20180001125376-18-000028
FY20161.65B91.8M50.0M0.908.2M5.5%10.9%10-K, Feb 8, 20170001125376-17-000013
  • Revenue, compound annual growth FY2016 to FY2025: 13.2%
  • Earnings, compound annual growth FY2016 to FY2025: 23.9%
  • Earnings per share, compound annual growth FY2016 to FY2025: 23.1%
  • Free cash flow, compound annual growth FY2016 to FY2019: 145.2%

Every figure in this section is a line of a filed annual statement or a ratio of two of them. Nothing here is estimated or smoothed. Earnings per share filed before a share split are put on today's share count, and say so. Nothing here is a verdict on the company.

8 of 10

Risks and guardrails

The accounting screens, the published tests, and the lines you can set to be told.

ComputedCompany statement

The Ensign Group, Inc: accounting screens and published tests, each with its source
FigureValue, source and document
Beneish M-score-2.53 ComputedFY2025 10-K, filed Feb 4, 2026, 0001125376-26-000007
Piotroski F-score5/9 ComputedFY2025 10-K, filed Feb 4, 2026, 0001125376-26-000007
Named tests met1 of 30 Computed
Beta0.12 ComputedClose of Oct 15, 2026

The named tests

Of 30 tests value investors published: 1 met, 28 not met, 1 we could not complete. Counts, never a score: a single figure would have to decide that meeting one investor’s criteria and meeting another’s are worth the same.

Which tests, by name(all 30)
Meets
ROIC at or above WACC
Does not
Defensive investor (Benjamin Graham); Deep value; Large cap, low P/E; Earnings yield and ROIC (Joel Greenblatt); High F-score, low P/B (Joseph Piotroski); Three forensic scores; Low PEG, low debt (Peter Lynch); High returns and growth; Gross margin, turnover (Robert Novy-Marx); EV/EBITDA and coverage; High yield, low payout; Dividends and buybacks; Low beta, profitable; Near the 52-week low; Z-score and coverage (Edward Altman); Two thirds of NCAV (Benjamin Graham); P/E times P/B (Benjamin Graham); High returns, low debt; Owner earnings yield; High return on tangibles; Low P/S, rising earnings (James O'Shaughnessy); Book or below, low debt (Walter Schloss); Tangible book or below; Cash-flow yield and ROIC; Clean books, high ROIC; Cheapest quarter on P/E (David Dreman); Cheapest quarter on P/B (David Dreman); Low P/E, growth, yield (John Neff)
Not measured
Cash-covered dividend. A test with a figure we could not read is incomplete, never met and never failed.
Figures we could not read(3)
  • Free Cash Flow Yield: We do not hold this figure for this company, so there is nothing to show.
  • Capex To Ocf: We do not hold this figure for this company, so there is nothing to show.
  • Dividend Coverage Ratio: We do not hold this figure for this company, so there is nothing to show.

9 of 10

Declared positions

Whether anybody here owns this company.

Positions declared by Javier Sanz Alvarez: no holding in any company shown here, as of October 3, 2026.

10 of 10

Next step

What to do with what you have read.

A thesis is your reason for owning it, in your words, with the figures that must stay true. Checking those figures every night against the newest filed accounts, and telling you once when one breaks, is what the subscription adds.

More on this company

What this cannot tell you

  • 3 figures could not be read on this company: Free Cash Flow Yield, Capex To Ocf, Dividend Coverage Ratio. 1 named test comes back incomplete because of them, which is neither met nor missed.

And the one that is true of all of it: This is what the numbers say today. It cannot tell you the day one of them stops being true. Nothing here can, because the reasons are not written down.

Running this once is arithmetic on public documents and you are welcome to it. Writing down why you own each company, in your own words and with the numbers that have to stay true for it to hold, and then having those numbers re-checked every night against the newest filed accounts, and against the latest close where a rule watches a price, is Professional, the plan a new account starts on for 30 days, one trial per person. It writes to you the day one breaks, and stays quiet when nothing does. The check runs every night at 23:30 UTC. A filing is picked up the night after it is published.

Monitor my portfolioHow this is computed

No card. 30 free days, and nothing is charged unless you choose a plan.

Analyze your own portfolio

ValueScreener · valuescreener.ai · Computed from accounts filed with the SEC by this company, read from EDGAR, and from dated closing prices. On this page a filed figure opens into its formula, its inputs and the statement, fiscal year and filing date it was read from, and a price into the day of its close. A figure that cannot show that trail says so.

A computation on accounts filed with the SEC, not a recommendation and not advice. Past filings do not indicate future results. Risk disclaimer.

Margin Notes

Once a week, what changed in the filings of US-listed companies, why it can matter to a thesis, and what deserves a closer review. Grounded in filings, not market noise.

Site map

Apps

  • Android app coming soon
  • iPhone app coming soon
ValueScreener

Discover companies, research each one to its filings, track what matters, and take your work into your own spreadsheet.

ValueScreener is a trading name of Oliva Real Estate Technologies LLC, a Delaware limited liability company. Legal notices: legal@valuescreener.ai. © 2026 Oliva Real Estate Technologies LLC. All rights reserved.

Risk disclaimer. This service is provided for research and education only. Nothing on it is investment advice, a recommendation, or an offer to buy or sell any security. Capital is at risk, and past performance does not indicate future results. Figures come from filed accounts and may be incomplete, delayed or later restated, so verify a number against the filing before you act on it.

With your permission, Google Analytics, Microsoft Clarity and HubSpot set cookies to measure how this site and the product are used, including recordings of sessions. Nothing is set unless you allow it. Privacy policy